The Wright Hip Implant Metallosis Class Action represents one of the largest hip implant recall settlements in medical device litigation history, with Wright Medical paying $330 million to resolve approximately 2,000 lawsuits involving faulty hip replacement systems. The settlement stemmed from defective metal-on-metal hip designs—specifically the Conserve, Dynasty, Lineage, and Profemur implant systems—which released dangerous levels of cobalt and chromium ions into patients’ bodies, causing a condition called metallosis. For example, a 58-year-old patient who received a Wright Conserve hip implant in 2008 developed severe metallosis within four years, requiring emergency revision surgery and resulting in permanent soft tissue damage and chronic pain. Wright Medical’s metal-on-metal hip implants were marketed as a breakthrough technology offering superior durability and range of motion compared to traditional designs.
However, clinical data revealed a troubling reality: by 2010, nearly one in five Wright Conserve hips required revision surgery within just five years of implantation—a failure rate far exceeding industry standards. The company ultimately paid settlements in two phases: approximately $240 million in November 2016 and an additional $90 million in October 2017, with individual payouts ranging from $120,000 to $170,000 depending on the implant model. This litigation exposed systemic problems in how hip implants were designed, tested, and approved for market use. Despite mounting clinical evidence of failures, Wright Medical continued selling these devices for years while downplaying safety concerns to surgeons and patients. The settlement, which closed the federal multidistrict litigation in June 2018, provided compensation for revision surgeries, medical expenses, and pain and suffering—but many patients continue to face ongoing health complications.
Table of Contents
- What Caused the Wright Hip Implant Metallosis Crisis?
- Understanding Metallosis and Its Long-Term Health Effects
- Settlement Amounts and How Much Patients Recovered
- Joining the Settlement and Filing a Claim
- The Hidden Danger: Revision Surgery Rates and Complications
- Other Problematic Hip Implants and Similar Metallosis Cases
- What Happened to Wright Medical and Current Status
- Conclusion
What Caused the Wright Hip Implant Metallosis Crisis?
Wright Medical’s troubled hip implant designs used metal-on-metal articulation, where the ball and cup of the replacement joint were both made from cobalt-chromium alloy. The company promoted this technology as more durable and offering better mobility than traditional metal-on-plastic designs. However, the metal-on-metal design created a serious problem: with every movement and friction between the components, the implants shed tiny metal particles and released cobalt and chromium ions directly into patients’ bloodstreams and surrounding tissue. The metallosis caused by these ions damaged the soft tissue around the implant, triggered inflammatory immune responses, and led to implant loosening and failure.
Additionally, the high levels of metal ions accumulating in the body raised serious health concerns about long-term toxicity effects. Some patients experienced bone loss around the implant (osteolysis), while others developed what doctors called adverse local tissue reactions (ALTR). For instance, a 52-year-old patient who received a Wright Dynasty implant underwent testing three years post-surgery and was found to have cobalt levels in her blood 50 times higher than normal, with imaging showing significant bone loss around the implant. What made this crisis particularly troubling was that Wright Medical had access to clinical data showing the problems years before taking action. International registries and published studies documented the high failure rates of metal-on-metal hips as early as 2008-2010, yet the company continued marketing these devices as safe and effective.
Understanding Metallosis and Its Long-Term Health Effects
Metallosis is an inflammatory reaction caused by the accumulation of metal particles and metal ions in the body surrounding an implant. In patients with Wright hip implants, this condition led to progressive tissue destruction, chronic pain, and ultimately implant failure requiring revision surgery. The condition doesn’t always produce obvious symptoms initially—some patients reported gradual worsening of pain and restricted mobility, while others experienced sudden complications when the damage became severe enough to cause implant loosening. The challenge with metallosis is that it’s irreversible.
Once cobalt and chromium ions accumulate in a patient’s body, the damage to surrounding soft tissue and bone is permanent. Even after successful revision surgery to replace the failed implant with a safer design, many patients experience chronic pain, reduced hip function, and complications from the extensive surgical intervention required to remove the failed implant and clean out the damaged tissue. A 60-year-old woman who had a Wright Conserve implant for six years developed metallosis requiring revision surgery; the surgeon discovered extensive tissue necrosis and bone loss that required reconstruction with bone graft material. Even after revision, she reported persistent weakness and pain compared to her hip function before the original implant failed. One important limitation of the settlement is that it covers the costs of revision surgery and associated medical expenses, but cannot reverse the underlying tissue damage or compensate for permanent loss of hip function and mobility that some patients experience even after successful revision.
Settlement Amounts and How Much Patients Recovered
The Wright Medical settlement was structured in two phases. The first settlement, announced in November 2016, involved approximately $240 million paid to cover nearly 1,300 patients who had sued over the defective Conserve implant. The second settlement, finalized in October 2017, involved an additional $90 million to resolve remaining lawsuits related to Dynasty, Lineage, and Profemur implant systems. Individual settlement amounts varied based on the specific implant model and the extent of injury and medical expenses.
Patients who received the Conserve implant—which had the highest failure rate—received an average of $170,000 per person, while those with Dynasty and Lineage implants received approximately $120,000 each. These amounts were calculated to cover revision surgery costs (which typically run $50,000 to $100,000), additional medical treatment, lost wages, pain and suffering, and future medical monitoring. For example, a 55-year-old male with a Wright Conserve implant who required revision surgery in 2014 and had ongoing complications received a settlement payment of $165,000, which covered his two surgeries, imaging studies, medical appointments, and compensation for his pain and suffering. It’s important to note that these settlement amounts represent averages—some cases with particularly severe complications settled for higher amounts, while others with less extensive injuries settled for lower amounts. Additionally, patients who had already won individual verdicts in jury trials sometimes received different amounts than those who accepted the class action settlement.
Joining the Settlement and Filing a Claim
To qualify for the Wright hip implant settlement, patients needed to have received one of the affected implant models (Conserve, Dynasty, Lineage, or Profemur) manufactured by Wright Medical and filed a lawsuit before the settlements were reached. The settlement process involved submitting documentation proving implant placement, evidence of metallosis diagnosis, and medical records supporting any revision surgery or ongoing treatment. The claims process required detailed medical records, including the original implant surgery report, diagnostic imaging (CT scans or X-rays) showing metallosis or implant failure, and documentation of any revision surgeries performed.
Patients typically worked with their personal injury attorney to submit claims, which included detailed forms describing their injuries and medical expenses. A key difference between this settlement and others is that patients didn’t have to prove Wright Medical’s negligence or secure a jury verdict—the company agreed to pay based on receiving the affected implant and meeting the settlement eligibility criteria. Because the multidistrict litigation closed in June 2018, new lawsuits against Wright Medical for hip implant metallosis are no longer part of the original settlement. However, patients who believe they received a Wright implant and have experienced complications should consult with a medical device attorney, as other legal options may still be available depending on their specific circumstances and the statute of limitations in their state.
The Hidden Danger: Revision Surgery Rates and Complications
The most alarming statistic from Wright Medical’s implant failures is the revision surgery rate: by 2010, nearly one in five (approximately 20%) of Wright Conserve hips required revision surgery within five years of implantation. To put this in perspective, revision rates for well-designed hip implants typically range from 2 to 5 percent over ten years. Wright’s 20 percent failure rate in just five years represented a medical catastrophe affecting thousands of patients. Revision surgery carries significant risks and complications beyond the original implant procedure. The surgery is more complex and time-consuming, requiring the surgeon to remove the failed implant, clean out damaged bone and tissue, and potentially use bone graft material to restore enough bone stock to accept a new implant.
Patients experience additional anesthesia risks, longer recovery times, increased risk of infection, and potential permanent complications such as persistent pain, reduced hip strength, and functional limitations even after successful revision. A 58-year-old woman who had a Wright Conserve implant placed in 2008 underwent revision surgery in 2013 when imaging showed metallosis and bone loss; the revision surgery required six hours under anesthesia and removal of significant bone tissue, followed by four months of limited mobility. Despite successful implant replacement, she experienced chronic weakness in that hip and never fully regained the mobility she had before the original implant failed. A critical warning about revision surgery is that not all complications can be resolved through surgery alone. Soft tissue damage from metallosis can be permanent, and patients may need to accept permanent functional limitations, ongoing pain management, and potential future surgeries if complications arise.
Other Problematic Hip Implants and Similar Metallosis Cases
Wright Medical’s hip implant failures were part of a broader wave of metal-on-metal hip implant recalls and litigation that affected multiple manufacturers in the 2010s. Other major hip implant metallosis lawsuits involved DePuy Synthes’ ASR system (resulting in a $2.5 billion settlement in 2013), Smith & Nephew, Stryker, and others. These cases shared similar problems: metal-on-metal designs that shed particles, causing tissue damage and requiring revision surgery.
The Wright case is notable for the relatively high average settlement amounts ($170,000 for Conserve implants) and the clear clinical documentation of failure rates. Unlike some other implant litigation where causation was debated, the Wright cases involved straightforward evidence of metallosis directly caused by the implant design and performance. This clarity in liability contributed to the relatively quick settlement resolution compared to other prolonged device litigation.
What Happened to Wright Medical and Current Status
Following the massive settlements and damaged reputation, Wright Medical discontinued its hip implant product line entirely. The company faced significant financial and legal consequences from the litigation, and the market had lost confidence in its hip implant systems. Today, Wright Medical no longer manufactures hip replacement implants, focusing instead on other orthopedic devices and surgical solutions.
The closure of the multidistrict litigation in June 2018 marked the official end of the major Wright hip implant litigation, though some individual cases or appeals may have continued afterward. For patients with failed Wright implants, the settlement provided a path to compensation, but many continue to live with permanent physical consequences from metallosis and revision surgeries. The case serves as a cautionary reminder about the importance of rigorous long-term testing, transparent reporting of implant failure rates to surgeons and patients, and the potential for serious harm when manufacturers prioritize profit over safety in medical device design.
Conclusion
The Wright Hip Implant Metallosis Class Action settled for $330 million to compensate approximately 2,000 patients who suffered injuries from defective metal-on-metal hip implants. The settlement recognized that Wright Medical’s Conserve, Dynasty, Lineage, and Profemur implant systems released dangerous levels of cobalt and chromium ions, causing metallosis, bone loss, and implant failure requiring revision surgery. With nearly one in five Conserve hips failing within five years and average settlement payouts of $120,000 to $170,000, the case highlighted the serious gaps that can exist in medical device safety oversight.
If you received a Wright Medical hip implant and have experienced pain, restricted mobility, or complications suggesting possible metallosis, consult with an orthopedic surgeon for diagnostic imaging and evaluation. While the original settlement litigation has closed, an experienced medical device attorney can review your situation and advise you on any remaining legal options. Document all medical records, imaging studies, and treatment costs, as these will be essential if you pursue any claims or legal action related to your hip implant complications.